Security Snapshot

U S PHYSICAL THERAPY INC /NV - Common Stock, par value $0.01 per share (USPH) Institutional Ownership

CUSIP: 90337L108

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

216

Shares (Excl. Options)

16.2MFull value: 16,196,529 · shares · 30 Jun 2026

Price

$68.68

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.01 per share
Symbol
USPH on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
16,196,529
Latest holder snapshot 5 signals
Total 13F value
$1,112,679,111
Portfolio coverage rank
0%
Share change
+143,417
Value change
+$7,960,962
Number of holders
216
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
14,929,016
SEC-reported price per share
$85.73
Insider filing price
$85.73
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • USPH - U S PHYSICAL THERAPY INC /NV - Common Stock, par value $0.01 per share is tracked under CUSIP 90337L108.
  • 216 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 228 to 216 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $1.2BFull value: $1,203,770,157 · USD · 31 Mar 2026
    to
    $1.11BFull value: $1,112,679,111 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 216 institutions filings for Q2 2026.

Open SEC evidence

Security key

90337L108

13F reference period

Q2 2026

13F holders

216

13D/G owners

5

CIK / CUSIP context first

Open Q2 2026 holders USPH full holder history U S PHYSICAL THERAPY INC /NV SEC filings U S PHYSICAL THERAPY INC /NV company facts U S PHYSICAL THERAPY INC /NV insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
USPH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 14% $169,079,035 2,162,136 BlackRock, Inc. 30 Jun 2025
Copeland Capital Management, LLC 6.3% +13% $80,633,817 +$8,486,146 940,528 +12% Copeland Capital Management, LLC 30 Sep 2026
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 5.6% -30% $62,188,205 -$26,869,479 846,674 -30% Kayne Anderson Rudnick Investment Management, LLC 30 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.1% $58,731,373 777,590 Vanguard Capital Management 31 Mar 2026
MORGAN STANLEY 3.9% -33% $43,826,366 -$21,517,985 596,683 -33% Morgan Stanley 30 Jun 2026
As of 30 Jun 2026, 216 institutional investors reported holding
16.2MFull value: 16,196,529 · shares · 30 Jun 2026
shares of U S PHYSICAL THERAPY INC /NV - Common Stock, par value $0.01 per share (USPH). This represents 108% of the company’s total
14.93MFull value: 14,929,016 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
86%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 2,264,202 +2.5% 0% $155,505,384
Bahl & Gaynor LLC 5.8% 861,574 +1.9% 0.27% $59,172,902
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 5.7% 846,674 -21% 0.18% $58,149,593
Copeland Capital Management, LLC 5.6% 841,544 +0.56% 1.2% $57,797,252
STATE STREET CORP 4.7% 707,186 +9.1% 0% $48,578,366
MORGAN STANLEY 4.7% 698,690 -30% 0% $47,986,138
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 674,195 +1.5% 0% $46,303,713
NEUBERGER BERMAN GROUP LLC 4% 598,894 +6375% 0.03% $41,132,040
AMERICAN CENTURY COMPANIES INC 3.7% 558,818 +66% 0.02% $38,379,976
SOUTHERNSUN ASSET MANAGEMENT, LLC 3.5% 527,765 +20% 4.9% $36,246,900
DIMENSIONAL FUND ADVISORS LP 3.4% 513,913 +1.3% 0.01% $35,295,934
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.9% 436,996 +16% 0.09% $30,012,885
SCHRODER INVESTMENT MANAGEMENT GROUP 2.9% 433,745 +69% 0.02% $29,850,331
GEODE CAPITAL MANAGEMENT, LLC 2.6% 385,726 +5.4% 0% $26,496,888
Boston Trust Walden Corp 2.6% 381,125 -4.7% 0.2% $26,175,665
GW&K Investment Management, LLC 2.4% 359,176 -2.6% 0.19% $24,668,000
VANGUARD PORTFOLIO MANAGEMENT LLC 2.2% 329,161 +5.4% 0% $22,606,777
BANK OF AMERICA CORP /DE/ 1.9% 282,192 -49% 0% $19,380,918
NORTHERN TRUST CORP 1.5% 230,937 +9.5% 0% $15,860,753
ENVESTNET ASSET MANAGEMENT INC 1.4% 204,339 -25% 0% $14,033,984
CRAWFORD INVESTMENT COUNSEL INC 1.2% 179,078 +18% 0.2% $12,299,082
FMR LLC 0.96% 143,226 -3.2% 0% $9,836,753
KENNEDY CAPITAL MANAGEMENT LLC 0.95% 141,098 +108% 0.17% $9,690,611
ROYAL BANK OF CANADA 0.94% 140,054 +4.7% 0% $9,620,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.92% 137,129 -6.7% 0% $9,418,020

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,240,459 $106,334,720 +$9,637,648 $85.73 55
2026 Q2 16,196,529 $1,112,679,111 +$7,960,962 $68.68 216
2026 Q1 16,053,966 $1,203,770,157 +$3,410,962 $74.96 228
2025 Q4 16,007,650 $1,251,280,500 -$3,483,427 $78.09 229
2025 Q3 16,025,734 $1,361,095,362 +$39,363,325 $84.95 244
2025 Q2 15,603,014 $1,220,352,681 +$28,791,118 $78.20 237
2025 Q1 15,293,795 $1,107,121,992 -$19,791,948 $72.36 252
2024 Q4 15,565,122 $1,381,034,235 +$12,224,751 $88.71 254
2024 Q3 15,433,476 $1,305,757,796 +$18,383,601 $84.63 254
2024 Q2 15,172,253 $1,402,254,310 -$59,249,178 $92.42 240
2024 Q1 15,618,754 $1,762,911,037 +$17,934,190 $112.87 234
2023 Q4 15,447,185 $1,438,773,106 +$3,869,053 $93.14 211
2023 Q3 15,398,086 $1,412,523,676 +$4,037,253 $91.73 216
2023 Q2 15,234,561 $1,848,475,452 +$186,901,768 $121.39 210
2023 Q1 13,701,294 $1,341,722,062 +$28,779,416 $97.91 195
2022 Q4 13,436,114 $1,088,773,930 +$71,739,919 $81.03 194
2022 Q3 13,124,739 $998,171,735 -$72,742,621 $76.02 189
2022 Q2 13,042,508 $1,423,973,455 +$34,859,639 $109.20 203
2022 Q1 12,815,293 $1,273,306,835 +$8,895,292 $99.45 203
2021 Q4 12,738,854 $1,217,788,483 -$20,797,020 $95.55 205
2021 Q3 12,685,017 $1,403,954,486 -$3,110,434 $110.60 203
2021 Q2 12,698,610 $1,471,332,128 +$13,558,739 $115.87 213
2021 Q1 12,599,376 $1,311,957,414 -$14,349,614 $104.10 206
2020 Q4 12,764,246 $1,535,159,218 -$22,751,760 $120.25 197
2020 Q3 12,985,104 $1,128,051,401 -$46,160,851 $86.88 176
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .